HC Surgical Specialists 관리

관리 기준 확인 2/4

HC Surgical Specialists CEO는 Sieu Min Heah, Sep2015 에 임명되었습니다 의 임기는 9.17 년입니다. 는 SGD 17.60M 가치에 해당하는 회사 주식의 41.6% 직접 소유합니다. 17.60M. 경영진과 이사회의 평균 재임 기간은 각각 5.6 년과 8.2 년입니다.

주요 정보

Sieu Min Heah

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	9.2yrs
CEO 소유권	41.6%
경영진 평균 재임 기간	5.6yrs
이사회 평균 재임 기간	8.2yrs

최근 관리 업데이트

Recent updates

CEO

Sieu Min Heah (60 yo)

9.2yrs

테뉴어

Dr. Sieu Min Heah, MB BCh, FRCSEd (General Surgery), FAMS General Surgery, has been Chief Executive Officer and Executive Director of HC Surgical Specialists Limited since September 1, 2015.

리더십 팀

이름	위치	테뉴어	보상	소유권
Sieu Min Heah	CEO & Executive Director	9.2yrs	데이터 없음	41.6% SGD 17.6m
Soo Ling Ong	Chief Financial Officer	8.8yrs	데이터 없음	데이터 없음
Josephine Tio Melissa	Chief Operating Officer	2.5yrs	데이터 없음	데이터 없음
Kok Hoong Chia	Medical Director & Executive Director	no data	데이터 없음	22.6% SGD 9.6m
Gary Ng	Head of the Internal Audit	no data	데이터 없음	데이터 없음
Hui Theng Lee	Chief Nursing Officer	1.5yrs	데이터 없음	0.065% SGD 27.5k
Moi Heyang Lin	Joint Company Secretary	no data	데이터 없음	데이터 없음
Pei Chan Tang	Joint Company Secretary	no data	데이터 없음	데이터 없음

5.6yrs

평균 재임 기간

60yo

평균 연령

경험이 풍부한 관리: 1B1 의 관리팀은 노련하고 경험 (평균 재직 기간 5.6 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Sieu Min Heah	CEO & Executive Director	9.2yrs	데이터 없음	41.6% SGD 17.6m
Kok Hoong Chia	Medical Director & Executive Director	9.2yrs	데이터 없음	22.6% SGD 9.6m
Seng Soon Ooi	Independent Non-Executive Director	8.2yrs	데이터 없음	데이터 없음
Weng Hoe Chong	Independent Non-Executive Chairman	8.2yrs	데이터 없음	0.11% SGD 46.1k
Chye Lai Lim	Non-Independent Non-Executive Director	8.2yrs	데이터 없음	0.16% SGD 68.7k

8.2yrs

평균 재임 기간

60yo

평균 연령

경험이 풍부한 이사회: 1B1 의 이사회는 경험(평균 재직 기간 8.2 년)으로 간주됩니다.

HC Surgical Specialists 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

HC Surgical Specialists Limited, Annual General Meeting, Sep 30, 2024

Insufficient new directors

Insufficient new directors

HC Surgical Specialists Limited, Annual General Meeting, Sep 26, 2023

Insufficient new directors

Insufficient new directors

Recent updates

Full year 2024 earnings released: EPS: S$0.025 (vs S$0.02 in FY 2023)

HC Surgical Specialists Limited Proposes Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 31 May 2024, Payable on 25 November 2024

New minor risk - Financial data availability

HC Surgical Specialists Limited, Annual General Meeting, Sep 30, 2024

Insufficient new directors

First half 2024 earnings released: EPS: S$0.023 (vs S$0.014 in 1H 2023)

HC Surgical Specialists Limited Declares Interim Dividend for the Financial Year Ending 31 May 2024, Payable on 13 March 2024

HC Surgical Specialists Limited Declares Interim Dividend, Payable on 13 March 2024

Insufficient new directors

Upcoming dividend of S$0.01 per share at 6.3% yield

HC Surgical Specialists Limited Approves A Final Dividend for the Financial Year Ended 31 May 2023

New minor risk - Shareholder dilution

HC Surgical Specialists Limited Proposes Final Dividend for the Financial Year Ended 31 May 2023

HC Surgical Specialists Limited, Annual General Meeting, Sep 26, 2023

Full year 2023 earnings released: EPS: S$0.019 (vs S$0.043 in FY 2022)

New minor risk - Financial data availability

Insufficient new directors

Insufficient new directors

Upcoming dividend of S$0.01 per share at 4.9% yield

HC Surgical Specialists Limited Announces Interim Dividend for the Financial Year Ending 31 May 2023, Payable on 13 March 2023

First half 2023 earnings released

Insufficient new directors

Insufficient new directors

Upcoming dividend of S$0.012 per share

HC Surgical Specialists Limited Approves Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 31 May 2022

Now 21% undervalued after recent price drop

HC Surgical Specialists Limited, Annual General Meeting, Sep 27, 2022

Full year 2022 earnings released: EPS: S$0.043 (vs S$0.053 in FY 2021)

HC Surgical Specialists Limited Recommends Final Dividend for the Financial Year Ended May 31, 2022

HC Surgical Specialists Limited Appoints Melissa Josephine Tio @ Melissa Josephine Susantio as Chief Operating Officer, Effective 1 May 2022

Insufficient new directors

HC Surgical Specialists Limited Announces Resignation of Chief Operating Officer, Ouyang Yuxia, Connie, Effective 30 April 2022

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of S$0.023 per share

Upcoming dividend of S$0.023 per share

Full year 2021 earnings released: EPS S$0.053 (vs S$0.027 in FY 2020)

HC Surgical Specialists Limited Announces That the Court of Appeal Dismissed

First half 2021 earnings released: EPS S$0.033

New 90-day high: S$0.42

HC Surgical Specialists Limited (Catalist:1B1) agreed to acquire remaining 30% stake in Julian Ong Endoscopy & Surgery (Pte Ltd).

HC Surgical Specialists Limited (Catalist:1B1) acquired 20% stake in Healthcare Essentials Pte. Ltd. from Lim Chye Lai, Gjan for SGD 0.18 million.

HC Surgical Specialists Provides Cashless and Convenient Healthcare Services to Eligible 1 Customers of Prudential Singapore

New 90-day high: S$0.35

New 90-day high - S$0.34

Full year earnings released - EPS S$0.023

New 90-day low - S$0.29

HC Surgical Specialists Limited completed the acquisition of additional 19% stake in Julian Ong Endoscopy & Surgery (Pte Ltd) from Julian Ong Surgery Pte. Ltd. for $3.8 million.

HC Surgical Specialists Limited (Catalist:1B1) completed the acquisition of additional 19% stake in Julian Ong Endoscopy & Surgery Pte. Ltd from Julian Ong Surgery Pte. Ltd.

CEO

테뉴어

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령